Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Takao Fujii »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Takao Endo < Takao Fujii < Takao Hinoi  Facettes :

List of bibliographic references indexed by Takao Fujii

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000156 (2020) Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000191 (2020) Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.
001379 (2018) Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Wararu Yamamoto [Japon] ; Takanori Fujimura [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Ohnishi [Japon] ; Kengo Akashi [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Toru Hirano [Japon] ; Kosuke Ebina [Japon] ; Ryuji Uozumi [Japon] ; Hiromu Ito [Japon] ; Masao Tanaka [Japon] ; Koichiro Ohmura [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon]Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.
001404 (2018) Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study.
001876 (2017) Shuichiro Nakabo ; Motomu Hashimoto ; Shinji Ito ; Moritoshi Furu [Japon] ; Hiromu Ito [Japon] ; Takao Fujii ; Hajime Yoshifuji ; Yoshitaka Imura ; Ran Nakashima ; Kosaku Murakami ; Nobuo Kuramoto ; Masao Tanaka ; Junko Satoh ; Akihito Ishigami [Japon] ; Satoshi Morita [Japon] ; Tsuneyo Mimori ; Koichiro OhmuraCarbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies
001974 (2016) Naonobu Sugiyama [Japon] ; Yutaka Kawahito [Japon] ; Takao Fujii [Japon] ; Tatsuya Atsumi [Japon] ; Tatsunori Murata [Japon] ; Yosuke Morishima [Japon] ; Yuri Fukuma [Japon]Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data.
001A31 (2016) Sumie Hiramatsu ; Koichiro Ohmura ; Hideaki Tsuji ; Hiroshi Kawabata ; Toshiyuki Kitano ; Ayuko Sogabe ; Motomu Hashimoto ; Kosaku Murakami ; Yoshitaka Imura ; Naoichiro Yukawa ; Hajime Yoshifuji ; Takao Fujii ; Akifumi Takaori-Kondo ; Tsuneyo MimoriSuccessful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
002014 (2015) Ryoko Sakai [Japon] ; Soo-Kyung Cho [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Michi Tanaka [Japon] ; Ryuji Koike [Japon] ; Yoshiya Tanaka [Japon] ; Kazuyoshi Saito [Japon] ; Shintaro Hirata [Japon] ; Koichi Amano [Japon] ; Hayato Nagasawa [Japon] ; Takayuki Sumida [Japon] ; Taichi Hayashi [Japon] ; Takahiko Sugihara [Japon] ; Hiroaki Dobashi [Japon] ; Shinsuke Yasuda [Japon] ; Tetsuji Sawada [Japon] ; Kazuhiko Ezawa [Japon] ; Atsuhisa Ueda [Japon] ; Takao Fujii [Japon] ; Kiyoshi Migita [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
002340 (2014) Toshiki Nakajima [Japon] ; Daisuke Kawabata ; Shuichiro Nakabo ; Aya Miyagawa-Hayashino ; Naoichiro Yukawa ; Hajime Yoshifuji ; Koichiro Ohmura ; Takao Fujii ; Tsuneyo MimoriSuccessful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis.
002417 (2014) Motomu Hashimoto [Japon] ; Takao Fujii [Japon] ; Masahide Hamaguchi [Japon] ; Moritoshi Furu [Japon] ; Hiromu Ito [Japon] ; Chikashi Terao [Japon] ; Keiichi Yamamoto [Japon] ; Wataru Yamamoto [Japon] ; Takashi Matsuo [Japon] ; Masato Mori [Japon] ; Koichiro Ohmura [Japon] ; Hiroshi Kawabata [Japon] ; Tsuneyo Mimori [Japon]Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.
003432 (2012) Rie Suematsu [Japon] ; Akihide Ohta ; Emi Matsuura ; Hiroki Takahashi ; Takao Fujii ; Takahiko Horiuchi ; Seiji Minota ; Yoshiaki Ishigatsubo ; Toshiyuki Ota ; Shuji Takei ; Sachiko Soejima ; Hisako Inoue ; Syuichi Koarada ; Yoshifumi Tada ; Kohei NagasawaTherapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan.
003572 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Takao Fujii" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Takao Fujii" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Takao Fujii
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021